TABLE 1.
History | Current test result | N | % of Total | CIN3+ cases | CIN3+ immediate risk (%) |
CIN3+ 3-y cumulative risk (%) |
Clinical management recommendation | Management confidence probability (%) |
---|---|---|---|---|---|---|---|---|
Not considered | HPV+/DS+ | 3,384 | 4.0 | 362 | 9.5 | 12.3 | Colposcopy | 100 |
Not considered | HPV+/DS− | 3,458 | 4.1 | 44 | 0.75 | 1.5 | 1-y return | 100 |
HPV-negative | HPV+/DS+ | 710 | 1.6 | 48 | 4.9 | 7.9 | Colposcopy | 86 |
HPV-negative | HPV+/DS− | 991 | 2.2 | 9 | 0.16 | 1.2 | 1-y return | 97 |
aThese results apply to HPV test results when limited genotyping is not available from the screening test.
CIN3+ indicates cervical intraepithelial neoplasia grade 3 or worse; DS, dual stain; HPV, human papillomavirus; KPNC, Kaiser Permanente Northern California.